Patents by Inventor Ana Victoria Morales-de-Echegaray

Ana Victoria Morales-de-Echegaray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TARGETED ANTIMICROBIAL PHOTODYNAMIC THERAPY
    Publication number: 20200289649
    Abstract: The present application relates generally to a method and a composition matter that provides a rapid and potent antimicrobial photodynamic inactivation (aPDI) of pathogenic bacteria that express high-affinity cell-surface hemin receptors (CSHRs) using Ga(III)-protoporphyrins IX (GaPpIX or Ga-PpIX). The invention provides an effective treatment option for infections of skin or body cavities that are accessible to visible-light irradiation, such as a handheld LED array emitting visible light (405 nm), especially for infections caused by Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus (MRSA), pathogenic staphylococci, Streptococcus mutans, S. pneumoniae, S. pyogenes, streptococci, corynebacteria, mycobacteria, and Bacillus anthracis.
    Type: Application
    Filed: May 29, 2020
    Publication date: September 17, 2020
    Applicant: Purdue Research Foundation
    Inventors: Alexander Wei, Ana Victoria Morales-de-Echegaray
  • Targeted antimicrobial photodynamic therapy
    Patent number: 10722582
    Abstract: The present application relates generally to a method and a composition matter that provides a rapid and potent antimicrobial photodynamic inactivation (aPDI) of pathogenic bacteria that express high-affinity cell-surface hemin receptors (CSHRs) using Ga(III)-protoporphyrins IX (GaPpIX or Ga-PpIX). The invention provides an effective treatment option for infections of skin or body cavities that are accessible to visible-light irradiation, such as a handheld LED array emitting visible light (405 nm), especially for infections caused by Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus (MRSA), pathogenic staphylococci, Streptococcus mutans, S. pneumoniae, S. pyogenes, streptococci, corynebacteria, mycobacteria, and Bacillus anthracis.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: July 28, 2020
    Assignee: Purdue Research Foundation
    Inventors: Alexander Wei, Ana Victoria Morales-de-Echegaray
  • TARGETED ANTIMICROBIAL PHOTODYNAMIC THERAPY
    Publication number: 20190314502
    Abstract: The present application relates generally to a method and a composition matter that provides a rapid and potent antimicrobial photodynamic inactivation (aPDI) of pathogenic bacteria that express high-affinity cell-surface hemin receptors (CSHRs) using Ga(III)-protoporphyrins IX (GaPpIX or Ga-PpIX). The invention provides an effective treatment option for infections of skin or body cavities that are accessible to visible-light irradiation, such as a handheld LED array emitting visible light (405 nm), especially for infections caused by Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus (MRSA), pathogenic staphylococci, Streptococcus mutans, S. pneumoniae, S. pyogenes, streptococci, corynebacteria, mycobacteria, and Bacillus anthracis.
    Type: Application
    Filed: March 29, 2019
    Publication date: October 17, 2019
    Applicant: Purdue Research Foundation
    Inventors: Alexander Wei, Ana Victoria Morales-de-Echegaray